Transfusion Trial to Prevent Platelet Alloimmunization

Schiffer, Charles Alan

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01HL042815-07
• Application #: 2220698
• Study Section: Clinical Trials Review Committee (CLTR)
• Project Start: 1989-08-01
• Project End: 1997-01-31
• Budget Start: 1995-08-01
• Budget End: 1997-01-31
• Support Year: 7
• Fiscal Year: 1995

Institution

• Name: University of Maryland Baltimore
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 003255213
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21201

Publications

Slichter, Sherrill J; Bolgiano, Douglas; Kao, Kuo-Jang et al. (2011) Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products. Transfus Med Rev 25:102-10

Slichter, Sherrill J; Davis, Kathryn; Enright, Helen et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:4106-14